Rani Therapeutics, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Rani Therapeutics, LLC - overview
Established
2012
Location
San Jose, CA, US
Primary Industry
Biotechnology
About
Based in California, US, Rani Therapeutics, LLC was founded in 2012 by founder Mir Imran. The company as of December 2020 has raised a total of 7 funding rounds. Rani Therapeutics' strategy and technology were created at InCube Labs, a multidisciplinary R&D center focused on generating medical advances. In April 2021, Rani Therapeutics filed to become a public company.
The company developed a "RaniPill capsule" that can be used to treat diabetes, rheumatoid arthritis, psoriasis, plaque psoriasis, and ankylosing spondylitis, providing patients with an alternative to painful and cumbersome medication injection methods. The company plans to be listed on the Nasdaq under the symbol RANI.
Current Investors
Novartis Venture Fund, AstraZeneca, InCube Ventures
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.ranitherapeutics.com
Verticals
Manufacturing
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.